CORC

在结果中检索

CORC

浏览/检索结果: 共56条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文
CANCER MEDICINE, 2022
作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan
收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei
收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载：29/0  |  提交时间：2022/12/22
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong
收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan
收藏  |  浏览/下载：29/0  |  提交时间：2021/03/15
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma 期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12
作者:  Shen, Dijian;  Chen, Qixun;  Wu, Jie;  Li, Jianqiang;  Tao, Kaiyi
收藏  |  浏览/下载：37/0  |  提交时间：2021/04/26
PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:  Wei, Qing;  Yuan, Xing;  Li, Jingjing;  Xu, Qi;  Ying, Jieer
收藏  |  浏览/下载：29/0  |  提交时间：2020/11/30
Efficacy and Safety of Gefitinib as Third-line Treatment in NSCLC Patients With Activating EGFR Mutations Treated With First-line Gefitinib Followed by Second-line Chemotherapy A Single-Arm, Prospective, Multicenter Phase II Study (RE-CHALLENGE, 期刊论文
2019, 卷号: 42, 期号: 5, 页码: 432-439
作者:  Song, Yong;  Wu, Yi-Long;  Cao, Le-Jie;  Chen, Jian-Hua;  Ma, Zhi-Yong
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China 期刊论文
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 卷号: 62, 期号: 4
作者:  Chen, Yong;  Xu, Biao;  Wu, Zheyuan;  Wu, Jie;  Shen, Xin
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining? 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Hua, Jie;  Shi, Si;  Liang, Dingkong;  Liang, Chen;  Meng, Qingcai
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace